eSymposia | Advances in Cancer Immunotherapy
Short Talk: Targeting the Stress Response Kinase GCN2 Potentiates Anti-Tumor Immune Response
Aug 18, 2020 12:30pm ‐ Aug 18, 2020 12:45pm
, PhD, Rapt Therapeutics, Inc.
You must be logged in and own this session in order to post comments.
© 2022 Keystone Symposia & Digitell, Inc. All Rights Reserved